Urine Toxicology With Pharmacogenomic Interpretation Assay: UTOPIA

Pharmacokinetics of Liposomal Amphotericin B in Critically Ill vs. Non-critically Ill Hematological Patients: Exploration of Covariates

NCT03529617 ·Status: RECRUITING

A Single Dose Metabolism and Mass Balance Study of 14C-ABR-215050 in Healthy Subjects

NCT01048203 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Effect of ASP1707 on the Bodies of Healthy Male Subjects After a Single Dose of Radioactive ASP1707

NCT02106780 ·Status: COMPLETED ·Phase: PHASE1

Reduction of Adverse Drug Events and Readmissions

NCT02738047 ·Status: RECRUITING

Bioavailability of Avenanthramide-Enriched Oats in Healthy Older Adults

NCT01055717 ·Status: COMPLETED ·Phase: NA

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a New Formulation of Oritavancin in Healthy Volunteers

NCT02471690 ·Status: COMPLETED ·Phase: PHASE1

Absorption, Metabolism and Excretion Study of [14C]PBT2 and Absolute Bioavailability of PBT2

NCT02249728 ·Status: COMPLETED ·Phase: PHASE1

Absorption, Distribution, Metabolism And Excretion Study For GSK221149A

NCT00457925 ·Status: COMPLETED ·Phase: PHASE1

A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293

NCT02126514 ·Status: COMPLETED ·Phase: PHASE1

Effect of Cimetidine on the Single-Dose PK of IV- Administered MNTX

NCT01366378 ·Status: COMPLETED ·Phase: PHASE1

An Investigational Study to Determine the Drug Level Profile of BMS-986165 in Healthy Male Volunteers Following Transporter Inhibition.

NCT04086719 ·Status: COMPLETED ·Phase: PHASE1

A Trial to Evaluate the Impact of C21 on the Exposure of 4 Substrates in Healthy Volunteers

NCT05830799 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between CYP2C9 Inhibitor and Substrate

NCT00369304 ·Status: COMPLETED ·Phase: PHASE1

A Human Mass Balance Study to Determine the Total Recovery of Radioactivity in Urine and Faeces Following a Single Oral Dose of 14C Radiolabelled ONO-4053

NCT01909986 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 After Intravenous Administration in Healthy Volunteers

NCT03500627 ·Status: COMPLETED ·Phase: PHASE1

Single Dose and Multiple Dose Trial to Assess Pharmacokinetics of Obeticholic Acid (OCA)

NCT01933503 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Study of ABT-126 in Healthy Volunteers

NCT00959634 ·Status: COMPLETED ·Phase: PHASE1

Effect of Food on Pharmacokinetics of Obeticholic Acid (OCA)

NCT01914562 ·Status: COMPLETED ·Phase: PHASE1

A Two-part Pharmacokinetic Study of PXS-5382A in Healthy Adult Males

NCT04183517 ·Status: COMPLETED ·Phase: PHASE1

A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male Subjects

NCT01109680 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study to Measure the Effect of OP-101 After Being Administered Subcutaneous in Healthy Volunteers

NCT04321980 ·Status: COMPLETED ·Phase: PHASE1

Single Dose Absorption, Distribution, Metabolism, and Excretion Study of [14C]-CORT113176 in Healthy Male Participants

NCT04990310 ·Status: COMPLETED ·Phase: PHASE1

Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers

NCT03565861 ·Status: COMPLETED ·Phase: PHASE1

RDEA3170 AME Study

NCT01910506 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Study to Characterize Phenotyping Metrics of the "Basel" Cocktail After CYP Induction or Inhibition

NCT01386593 ·Status: COMPLETED ·Phase: PHASE1